483 AstraZeneca Pharmaceuticals LP Oct 2013

483 AstraZeneca Pharmaceuticals LP Oct 2013

Rebecca Dombrowski FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Mount Vernon, IN, United States facility and issued 2 inspectional observations (via FDA 483) on 25 Oct 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 25 Oct 2013
  • Location: Mount Vernon, United States
  • FEI: 1825662
Add To Cart